Pacific Bio (PACB) Tops Q3 EPS by 1c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $23.5 million versus the consensus estimate of $28.55 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
• Workhorse Group (WKHS) Misses Q2 EPS by 77c